Neogen stock rises after appointing Siemens Healthineers exec as CEO

Published 24/07/2025, 15:44
© Reuters.

Investing.com -- Neogen Corporation (NASDAQ:NEOG) stock rose 2.5% after the food safety solutions provider announced the appointment of Mike Nassif as its new Chief Executive Officer and President, effective August 11, 2025.

Nassif, who will also join Neogen’s Board of Directors, succeeds John Adent who is stepping down after eight years with the company. Nassif currently serves as Global President of the Point-of-Care Diagnostics business at Siemens (ETR:SIEGn) Healthineers, where he has been instrumental in driving significant growth.

"We are thrilled to welcome Mike to Neogen and our Board of Directors," said Jim Borel, Neogen’s Board Chair. "His extensive global experience in the diagnostics space, proven ability to drive growth, and track-record of developing and leading great teams make him the perfect fit for Neogen and our priority of achieving our growth, profitability and operational targets."

Nassif brings over two decades of leadership experience across healthcare, diagnostics, biopharma, and consumer goods sectors. Prior to Siemens Healthineers, he held senior leadership positions at Baxter (NYSE:BAX) Healthcare, AB-InBev, and Johnson & Johnson (NYSE:JNJ). He also served as a Captain in the United States Army Corps of Engineers.

The incoming CEO holds a Bachelor’s degree in Civil Engineering from the United States Military Academy at West Point and an MBA in Finance from the Wharton School.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.